Showing results (101-110 of 294) with videos related to
Sort By:
Pageof 30
Gut|August 31, 2010
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver diseaseStuart McPherson, Stephen F Stewart, Elsbeth Henderson, et al.Nature Metabolism|April 10, 2023
A proteo-transcriptomic map of non-alcoholic fatty liver disease signaturesOlivier Govaere, Megan Hasoon, Leigh Alexander, et al.Alimentary Pharmacology & Therapeutics|October 6, 2018
Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in GermanyChristian Labenz, Yvonne Huber, Eva Kalliga, et al.Journal of Hepatology|May 26, 2026
EASL position paper on preclinical models of steatotic liver diseaseSuchira Gallage, Rui E Castro, Jennifer Estall, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2018
Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic InflammationYvonne Huber, Marie Boyle, Kate Hallsworth, et al.JHEP Reports : Innovation in Hepatology|May 22, 2020
Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosisLorraine McSweeney, Matthew Breckons, Gulnar Fattakhova, et al.BMJ Open|March 31, 2022
Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) studyNeeta B Amin, Amanda Darekar, Quentin M Anstee, et al.Journal of Hepatology|December 7, 2023
NIS2+<sup>TM</sup> as a screening tool to optimize patient selection in metabolic dysfunction-associated steatohepatitis clinical trialsVlad Ratziu, Stephen A Harrison, Yacine Hajji, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 25, 2015
Variants in the LGALS9 Gene Are Associated With Development of Liver Disease in Heavy Consumers of AlcoholHugo R Rosen, Lucy Golden-Mason, Ann K Daly, et al.Gastroenterology|February 6, 2004
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic diseaseAmedeo Lonardo, Luigi E Adinolfi, Paola Loria, et al.Pageof 30